Crystal Pharmatech
PrivateLast Round
Series B
Dec 25, 2018
Total Funding Raised
$25.98M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Crystal Pharmatech operates in Healthcare & Life Sciences and is based in Cranbury, New Jersey. Its latest recorded funding round was a Series B round in December 2018.
Crystal Pharmatech is a pharmaceutical and biotechnology company that provides contract research and development manufacturing organization (CRO/CDMO) services, specializing in solid-state research, crystallization, preformulation, formulation development, and GMP manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Crystal Pharmatech Comparables
Compare Crystal Pharmatech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Triclinic Labs | 87% | |
| Improved Pharma | 87% | |
| Crystec Pharma | 81% |
For institutional investors. Book with your work email.
Crystal Pharmatech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 25, 2018 | ||||
| Series A | Sep 15, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Crystal Pharmatech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shiyu Capital | Series B |
| Oriza Seed Venture Capital | Series B |
| Cowin Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 65% MoM, reaching 9.4K.
- Dec 25, 2018
$15M round led by Shiyu Capital
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 10, 2026
In 2021, Crystal Pharmatech Inc. launched MicroED services using a cryo-electron microscope for data collection.
- attends_eventNov 5, 2026
Crystal Pharmatech Inc. attends Boston Symposium & Executive Networking Reception in Massachusetts on Nov 19th '26, where MicroED features in a talk and two posters.
For institutional investors. Book with your work email.
Crystal Pharmatech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Crystal Pharmatech's valuation, stock price, and market status.
Is Crystal Pharmatech a public or private company?
Crystal Pharmatech is a private company.
What is the current stock price of Crystal Pharmatech?
Crystal Pharmatech is a private company, so its shares have no public market price. Caplight tracks Crystal Pharmatech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Crystal Pharmatech worth (valuation)?
Valuation information for Crystal Pharmatech is not publicly available.
Can I buy Crystal Pharmatech stock?
Crystal Pharmatech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Crystal Pharmatech's last funding round?
Crystal Pharmatech's most recent funding round was Series B on December 25, 2018.
Who are the main investors in Crystal Pharmatech?
Key investors in Crystal Pharmatech include Shiyu Capital.
Will Crystal Pharmatech IPO soon?
No public IPO plans have been announced for Crystal Pharmatech.
How can I track Crystal Pharmatech secondary market activity?
Caplight tracks bids, offers, and trades in Crystal Pharmatech's shares on secondary markets.